NewcelX Ltd.(NCEL)

Biotechnology · Kloten, ZH

$2.97+0.15 (+5.28%)

Delayed quote: Oct 6, 2026, 2:28 PM EDT

EV/Sales Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/Sales ratio is N/A as of 2026-10-06T18:32:19.176Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:32:19.176Z.

Quote observation: 2026-10-06T18:28:22.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,336,500
Total debt · period ending 2026-06-30: 392,000
Cash · period ending 2026-06-30: 710,000
TTM revenue · period ending 2026-06-30: N/A

FMP input reference: ceb9d7bb150905ac81611c4688aa1bd793b2f4eb464ba4dc05e218b0340a6d90

EV/EBITDA|P/S Ratio|Revenue|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NCEL EV/Sales Ratio Metrics

EV/SALES RATIO

N/A

NCEL Competitors' EV/Sales Ratio

NCEL

NewcelX Ltd.

Current

Market Cap

$1.34M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNPX

Genprex, Inc.

vs NCEL

Market Cap

$1.35M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs NCEL

Market Cap

$1.36M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JUNS

Jupiter Neurosciences, Inc.

vs NCEL

Market Cap

$1.39M

EV/Sales Ratio

25.01x

TTM Avg

279.56x

3Y Avg

279.56x

5Y Avg

279.56x

IVF

INVO Fertility, Inc.

vs NCEL

Market Cap

$1.43M

EV/Sales Ratio

0.21x

TTM Avg

0.55x

3Y Avg

1.65x

5Y Avg

4.41x

NXGL

NEXGEL, Inc.

vs NCEL

Market Cap

$1.43M

EV/Sales Ratio

0.70x

TTM Avg

1.00x

3Y Avg

2.40x

5Y Avg

3.38x

CRIS

Curis, Inc.

vs NCEL

Market Cap

$1.43M

EV/Sales Ratio

N/A

TTM Avg

0.94x

3Y Avg

2.21x

5Y Avg

9.57x

ELAB

PMGC Holdings Inc.

vs NCEL

Market Cap

$1.48M

EV/Sales Ratio

N/A

TTM Avg

0.01x

3Y Avg

35696307.79x

5Y Avg

35696307.79x

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs NCEL

Market Cap

$1.49M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PPCB

Propanc Biopharma, Inc.

vs NCEL

Market Cap

$1.17M

EV/Sales Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
NewcelX Ltd. (NCEL)	$1.34M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.35M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.36M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.39M	25.01x	279.56x	279.56x	279.56x
INVO Fertility, Inc. (IVF)vs ›	$1.43M	0.21x	0.55x	1.65x	4.41x
NEXGEL, Inc. (NXGL)vs ›	$1.43M	0.70x	1.00x	2.40x	3.38x
Curis, Inc. (CRIS)vs ›	$1.43M	N/A	0.94x	2.21x	9.57x
PMGC Holdings Inc. (ELAB)vs ›	$1.48M	N/A	0.01x	35696307.79x	35696307.79x
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.49M	N/A	N/A	N/A	N/A
Propanc Biopharma, Inc. (PPCB)vs ›	$1.17M	N/A	N/A	N/A	N/A

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

It works for unprofitable companies where P/E doesn't apply
Revenue is harder to manipulate than earnings
It supports comparisons across companies at different profitability stages
It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA P/S Ratio Revenue All Metrics